Management Team
Per Andersson, Ph.D.Chief Executive OfficerPer Andersson joined XSpray in September 2006. He has more than 9 years of successful executive management experience in research, development and commercial operations. Most recently, Dr. Andersson served as Science Director of Gyros being one of the main inventors of the Gyros technology. Dr. Andersson has published more than 25 scientific publications and book chapters and is the inventor of more than 30 patent families (Assignee: University of Alberta and Gyros AB) Prior to Gyros Dr Andersson held a position as senior scientist at Amersham Pharamcia Biotech. He has commercial experience including business development and management of long term international partnerships. Dr. Andersson gained a Ph.D. in Analytical Chemistry from Stockholm University, Sweden in 1995 and have worked as a post-doc in Australia and Canada. |
 Per Andersson, CEO |
Mustafa Demirbüker, Ph.D.Science Director, Co-FounderCo-founded XSpray in November 2003 and has acted as Chief Scientific Officer and has more than 15 years of broad experience in the international pharmaceutical industry, including 10 years as a senior consultant for Astra Zeneca where he was responsible for the early development of industrial pharmaceutical particle formation using Supercritical Fluids. Dr. Demirbüker has over 20 publications and is the inventor of several patent families related to Supercritical Fluid technology. Dr Demirbüker received his Ph.D. in Analytical Chemistry from Stockholm University, Sweden in 1992. |
 Mustafa Demirbüker |
Gérald JessonVice President OperationsGérald Jesson joined XSpray in September 2007. His accomplishments include founding two companies in Sweden, one of which, Capture Device AB was sold to Biomotif AB in 2007. He worked for Gyros for 7 years as a Scientist, and has rigths to more than 15 patents. He has also worked at the Karolinska Institute in Stockholm and VIRBAC S.A. in Nice, France. |
 Gérald Jesson |
Mikael Bisrat, Ph.D.Chief Scientific Officer, Co-FounderCo-founder of XSpray. Mikael Bisrat has a Ph.D. in Pharmaceutical Science from Faculty of Pharmacy, Uppsala University and more than 15 years industrial experience both as Formulation Scientist, Research Scientist at Astra and as manager: Associate Director Pharmaceutical Development as Head of Preformulation at Astra/AstraZeneca and Manager and Director Pharmaceutics at Pharmacia Upjohn/Pharmacia. Prior to joining Xspray he held a Director Pharmaceutics position at Biovitrum. Dr Bisrat is a co-author of three patents in the area of supercritical crystallisation. |
 Mikael Bisrat |
Helene Dérand, Ph.D.Sales & Marketing DirectorHelene Dérand joined XSpray in March 2009. Dr. Dérand has broad-based experience gained from more than ten years in the biotechnology and medical technology sectors. She has held various management positions in both global and start-up companies with responsibilities ranging from R&D and clinical operations to business development. Dr. Dérand has published more than 20 scientific publications and book chapters and is the inventor of more than 15 patent families. Dr. Dérand gained a Ph.D. in Polymer Chemistry from Lund University, Sweden, in 1997. |
 Helene Dérand |